| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3545ae287efd5df26c7f31de1cba00a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5b0c5af2b97a5fc2a0da979cdc8e392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f503b76d4dfdb863d618e70e8e54803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7eb35e741192067b77c870b0c3d58be5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-11016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001154 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1473c4de38fda47068631d604e59fe5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dd090500675284dd71ff1ab6c189ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a64cb5b913e3ab85f05bcefa61e5da0d |
| publicationDate |
2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014271691-A1 |
| titleOfInvention |
Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase) |
| abstract |
The present invention encompasses a cancer vaccine therapy targeting Aspartyl-[Asparaginyl]-β-hydroxylase (HAAH). The present invention contemplate bacteriophage expressing HAAH peptide fragments and methods for using said bacteriophage in methods of treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020081996-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015306198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813984-B2 |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |